Recurrent breast cancer
Imaging of Male Breast Cancer, Page: 133-137
2015
- 40Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures40
- Readers40
- 40
Book Chapter Description
Studies devoted to survival analysis in men with breast carcinoma are significantly smaller than similar studies in women. In most cases, only the general survival rate is evaluated. The majority of authors agree that the prognosis in men with breast cancer is significantly worse than in women with similar disease (Dymarsky 1980; Guinee et al. 1993). The lower general survival rate in men results from an older age and later stages of the disease at the time of the diagnosis. According to the literature, the 5-year survival rate in men with breast carcinoma ranges from 36 to 66 % (Korde et al. 2010). The 10-year survival rates in patients with stage I-Ia is 91.5 %, IIb is 72.5 %, III is 44.2 %, and IV does not exceed 3.2 % (Guinee et al. 1993; Letyagin 2006).
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84944595665&origin=inward; http://dx.doi.org/10.1007/978-3-319-06050-7_9; https://link.springer.com/10.1007/978-3-319-06050-7_9; https://dx.doi.org/10.1007/978-3-319-06050-7_9; https://link.springer.com/chapter/10.1007/978-3-319-06050-7_9
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know